☆ 4.7 Article

Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan

ANNALS OF THE RHEUMATIC DISEASES (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Rheumatology

Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data

Ruriko Koto et al.

Summary: While the prevalence of hyperuricemia is similar in Japan and worldwide, gout is relatively rare in Japan. Gout and asymptomatic hyperuricemia are often treated with low-dose urate-lowering therapy (ULT), but many patients fail to achieve target serum uric acid levels, suggesting suboptimal gout management in Japan. Patients would benefit from a stricter focus on a treat-to-target approach for gout management.

MODERN RHEUMATOLOGY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data

Ruriko Koto et al.

Summary: This study examined factors associated with achieving target serum uric acid (sUA) levels and gouty arthritis in Japanese clinical practice. The findings suggest that older, female patients with higher urate-lowering therapy doses, better adherence, more comorbidities, and/or antidiabetic drug prescriptions were more likely to achieve target sUA. However, renal dysfunction and diuretic prescriptions were linked to reduced likelihood of achieving target sUA levels. Patients with a history of gouty arthritis occurrence were more likely to experience it again, while better adherence to urate-lowering therapy and regular sUA monitoring may help in managing gouty arthritis occurrences.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)

添加到收藏夹

Article Rheumatology

2020 American College of Rheumatology Guideline for the Management of Gout

John D. FitzGerald et al.

ARTHRITIS CARE & RESEARCH (2020)

添加到收藏夹

Article Medicine, General & Internal

Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

Atsushi Tanaka et al.

PLOS MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

A. Doria et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Effects of Allopurinol on the Progression of Chronic Kidney Disease

Sunil V. Badve et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy

Sunao Kojima et al.

EUROPEAN HEART JOURNAL (2019)

添加到收藏夹

Article Urology & Nephrology

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

Kenjiro Kimura et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2018)

添加到收藏夹

Article Rheumatology

Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study

Hisashi Yamanaka et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

添加到收藏夹

Review Rheumatology

Treat-to-target (T2T) recommendations for gout

U. Kiltz et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

添加到收藏夹

Review Rheumatology

2016 updated EULAR evidence-based recommendations for the management of gout

P. Richette et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

添加到收藏夹

Article Rheumatology

Effects of Febuxostat in Early Gout A Randomized, Double-Blind, Placebo-Controlled Study

Nicola Dalbeth et al.

ARTHRITIS & RHEUMATOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

The Effects of Allopurinol on the Carotid Intima-media Thickness in Patients with Type 2 Diabetes and Asymptomatic Hyperuricemia: A Three-year Randomized Parallel-controlled Study

Peng Liu et al.

INTERNAL MEDICINE (2015)

添加到收藏夹

Article Medicine, General & Internal

Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis

Robert Jackson et al.

BMJ OPEN (2015)

添加到收藏夹

Article Rheumatology

Frequency and risk factors of gout flares in a large population-based cohort of incident gout

Dietrich Rothenbacher et al.

RHEUMATOLOGY (2011)

添加到收藏夹

Article Public, Environmental & Occupational Health

Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage

Shinya Kimura et al.

JOURNAL OF EPIDEMIOLOGY (2010)

添加到收藏夹

Article Medicine, General & Internal

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

MA Becker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.